Credit Suisse’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,490
| Closed | -$2.23K | – | 3870 |
|
|
2022
Q4 | $2.23K | Buy |
+7,490
| New | +$2.23K | ﹤0.01% | 3530 |
|
|
2022
Q3 | – | Sell |
-30,000
| Closed | -$13K | – | 4431 |
|
|
2022
Q2 | $13K | Hold |
30,000
| – | – | ﹤0.01% | 3695 |
|
|
2022
Q1 | $38K | Hold |
30,000
| – | – | ﹤0.01% | 3507 |
|
|
2021
Q4 | $39K | Sell |
30,000
-14
| -0% | -$18 | ﹤0.01% | 3575 |
|
|
2021
Q3 | $62K | Sell |
30,014
-1,692
| -5% | -$3.5K | ﹤0.01% | 3475 |
|
|
2021
Q2 | $50K | Sell |
31,706
-4,045
| -11% | -$6.38K | ﹤0.01% | 3534 |
|
|
2021
Q1 | $80K | Sell |
35,751
-5,970
| -14% | -$13.4K | ﹤0.01% | 3346 |
|
|
2020
Q4 | $103K | Buy |
41,721
+11,285
| +37% | +$27.9K | ﹤0.01% | 3323 |
|
|
2020
Q3 | $75K | Sell |
30,436
-3,637
| -11% | -$8.96K | ﹤0.01% | 3184 |
|
|
2020
Q2 | $121K | Buy |
34,073
+495
| +1% | +$1.76K | ﹤0.01% | 3175 |
|
|
2020
Q1 | $78K | Buy |
33,578
+69
| +0.2% | +$160 | ﹤0.01% | 3253 |
|
|
2019
Q4 | $73K | Buy |
+33,509
| New | +$73K | ﹤0.01% | 3418 |
|
|
2019
Q3 | – | Sell |
-15,765
| Closed | -$23K | – | 3518 |
|
|
2019
Q2 | $23K | Buy |
+15,765
| New | +$23K | ﹤0.01% | 3397 |
|
|
2018
Q2 | – | Sell |
-11,672
| Closed | -$49K | – | 3608 |
|
|
2018
Q1 | $49K | Buy |
+11,672
| New | +$49K | ﹤0.01% | 3453 |
|
|
2017
Q4 | – | Sell |
-19,951
| Closed | -$76K | – | 3663 |
|
|
2017
Q3 | $76K | Buy |
+19,951
| New | +$76K | ﹤0.01% | 3635 |
|
|
2017
Q1 | – | Sell |
-28,359
| Closed | -$75K | – | 3664 |
|
|
2016
Q4 | $75K | Buy |
28,359
+8,017
| +39% | +$21.2K | ﹤0.01% | 3623 |
|
|
2016
Q3 | $66K | Buy |
20,342
+300
| +1% | +$973 | ﹤0.01% | 3643 |
|
|
2016
Q2 | $67K | Sell |
20,042
-40
| -0.2% | -$134 | ﹤0.01% | 3811 |
|
|
2016
Q1 | $49K | Sell |
20,082
-143
| -0.7% | -$349 | ﹤0.01% | 3587 |
|
|
2015
Q4 | $67K | Sell |
20,225
-14,076
| -41% | -$46.6K | ﹤0.01% | 3887 |
|
|
2015
Q3 | $118K | Buy |
+34,301
| New | +$118K | ﹤0.01% | 3857 |
|